Neuroimmunophilin Ligands Protect Cavernous Nerves after Crush Injury in the Rat: New Experimental Paradigms

European Urology

Volumn 51, Issue 6, 2007, Pages 1724-1731

  Valentine, Heather ^a   Chen, Yi ^a   Guo, Hongzhi ^a   McCormick, Jocelyn ^a   Wu, Yong ^a   Sezen, Sena F ^b   Hoke, Ahmet ^b   Burnett, Arthur L ^b   Steiner, Joseph P ^b  

^a GUILFORD PHARMACEUTICALS INC   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cavernous nerve injury; Erectile dysfunction; Immunophilin ligands

Indexed keywords

1 (3,3 DIMETHYL 1,2 DIOXOPENTYL) 2 PYRROLIDINECARBOXYLIC ACID 3 (3 PYRIDYL)PROPYL ESTER; NEUROIMMUNOPHILIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS CAVERNOSUM; DRUG BIOAVAILABILITY; ELECTROSTIMULATION; ERECTILE DYSFUNCTION; MALE; NERVE INJURY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT;

ADMINISTRATION, ORAL; ANALYSIS OF VARIANCE; ANIMALS; INJECTIONS, INTRAPERITONEAL; LIGANDS; MALE; NERVE CRUSH; NERVE REGENERATION; PENIS; PERIPHERAL NERVES; PROSTATECTOMY; PYRROLIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION; TACROLIMUS;

EID: 34247347022     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2006.11.026     Document Type: Article

References (29)

1. Burnett A.L. Erectile dysfunction following radical prostatectomy. JAMA 293 (2005) 2648-2653
2. Montorsi F., and McCullough A. Efficacy of sildenafil citrate in men with erectile dysfunction following radical prostatectomy: a systematic review of clinical data. J Sex Med 2 (2005) 658-667
3. Carrier S., Zvara P., Nunes L., et al. Regeneration of nitric oxide synthase-containing nerves after cavernous nerve neurotomy in the rat. J Urol 153 (1995) 1722-1727
4. Bochinski D., Lin G.T., Nunes L., et al. The effect of neural embryonic stem cell therapy in a rat model of cavernosal nerve injury. BJU Int 94 (2004) 904-909
5. Chen K.C., Minor T.X., Rahman N.U., et al. The additive erectile recovery effect of brain-derived neurotrophic factor combined with vascular endothelial growth factor in a rat model of neurogenic impotence. BJU Int 95 (2005) 1077-1080
6. Sezen S.F., Hoke A., Burnett A.L., and Snyder S.H. Immunophilin ligand FK506 is neuroprotective for penile innervation. Nat Med 7 (2001) 1073-1074
7. Kendirci M., Zsengeller Z., Bivalacqua T.J., et al. Poly(adenosine diphosphate-ribose) polymerase inhibition preserves erectile function in rats after cavernous nerve injury. J Urol 174 (2005) 2054-2059
8. Hsieh P.S., Bochinski D.J., Lin G.T., et al. The effect of vascular endothelial growth factor and brain-derived neurotrophic factor on cavernosal nerve regeneration in a nerve-crush rat model. BJU Int 92 (2003) 470-475
9. Poulter M.O., Payne K.B., and Steiner J.P. Neuroimmunophilins: a novel drug therapy for the reversal of neurodegenerative disease?. Neuroscience 128 (2004) 1-6
10. Burnett A.L., and Becker R.E. Immunophilin ligands promote penile neurogenesis and erection recovery after cavernous nerve injury. J Urol 171 (2004) 495-500
11. Brostoff S.W., Levit S., and Powers J.M. Induction of experimental allergic neuritis with a peptide from myelin P2 basic protein. Nature 268 (1977) 752-753
12. Larsen J.O. Stereology of nerve cross sections. J Neurosci Methods 85 (1998) 107-118
13. Steiner J.P., Hamilton G.S., Ross D.T., et al. Neurotrophic immunophilin ligands stimulate structural and functional recovery in neurodegenerative animal models. Proc Natl Acad Sci USA 94 (1997) 2019-2024
14. Harper S., Bilsland J., Young L., et al. Analysis of the neurotrophic effects of GPI-1046 on neuron survival and regeneration in culture and in vivo. Neuroscience 88 (1999) 257-267
15. Hoke A., Ho T., Crawford T.O., et al. Glial cell line-derived neurotrophic factor alters axon schwann cell units and promotes myelination in unmyelinated nerve fibers. J Neurosci 23 (2003) 561-567
16. Sezen S.F., Blackshaw S., Steiner J.P., and Burnett A.L. FK506 binding protein 12 is expressed in rat penile innervation and upregulated after cavernous nerve injury. Int J Impot Res 14 (2002) 506-512
17. Ide C. Peripheral nerve regeneration. Neurosci Res 25 (1996) 101-121
18. Keilhoff G., Fansa H., and Wolf G. Neuronal NOS deficiency promotes apoptotic cell death of spinal cord neurons after peripheral nerve transection. Nitric Oxide 10 (2004) 101-111
19. Thippeswamy T., Jain R.K., Mumtaz N., and Morris R. Inhibition of neuronal nitric oxide synthase results in neurodegenerative changes in the axotomised dorsal root ganglion neurons: Evidence for a neuroprotective role of nitric oxide in vivo. Neurosci Res 40 (2001) 37-44
20. Podlasek C.A., Gonzalez C.M., Zelner D.J., et al. Analysis of NOS isoform changes in a post radical prostatectomy model of erectile dysfunction. Int J Impot Res 13 Suppl 5 (2001) S1-S15
21. Gonzalez C.M., Brannigan R.E., Bervig T., et al. Protein and gene expression of nitric oxide synthase isoforms I and III in the rat penile shaft. J Androl 22 (2001) 54-61
22. Tanaka K.-i., Fujita N., Higashi Y., and Ogawa N. Neuroprotective and antioxidant properties of fkbp-binding immunophilin ligands are independent on the FKBP-12 pathway in human cells. Neurosc Lett 330 (2002) 147-150
23. Tanaka K.-i., Yoshioka M., Miyazaki I., Fujita N., and Ogawa N. GPI1046 prevents dopaminergic dysfunction by activating glutathione system in the mouse striatum. Neurosci Lett 321 (2002) 45-48
24. Tanaka K.-i., Fujita N., Yoshioka M., and Ogawa N. Immunosuppressive and non-immunosuppressive immunophilin ligands improve H2O2-induced cell damage by increasing glutathione levels in NG108-15 cells. Brain Res 889 (2001) 225-228
25. Gold B.G., and Villafranca J.E. Neuroimmunophilin ligands: The development of novel neuroregenerative/neuroprotective compounds. Curr Top Med Chem 3 (2003) 1368-1375
26. Lehnart S.E., Huang F., Marx S.O., and Marks A.R. Immunophilins and coupled gating of ryanodine receptors. Curr Top Med Chem 3 (2003) 1383-1391
27. Klettner A., and Herdegen T. The immunophilin-ligands FK506 and V-10,367 mediate neuroprotection by the heat shock response. Br J Pharmacol 138 (2003) 1004-1012
28. Ganel R., Ho T., Maragakis N.J., et al. Selective up-regulation of the glial Na+-dependent glutamate transporter GLT1 by a neuroimmunophilin ligand results in neuroprotection. Neurobiol Dis 21 (2006) 556-567
29. Edlich F., Weiwad M., Erdmann F., et al. Bcl-2 regulator FKBP-38 is activated by ca2+/calmodulin. EMBO J 24 (2005) 2688-2699